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Abstract
           Radiofrequency ablation has an important role in the management of post infarction
ventricular tachycardia.  The mapping and ablation of ventricular tachycardia (VT) is complex
and technically challenging.  In the era of implantable cardioverter defibrillators, the role of
radiofrequency ablation is most commonly reserved as an adjunctive treatment for patients with
frequent, symptomatic episodes of ventricular tachycardia. In this setting the procedure has a
success rate of around 70-80% and a low complication rate.  With improved ability to predict
recurrent VT and improvements in mapping and ablation techniques and technologies, the role of
radiofrequency ablation should expand further. 
Introduction
           Radiofrequency ablation (RFA) is the treatment of choice in the management of
symptomatic patients with ventricular tachycardia (VT) in the absence of structural heart disease.
The role of RFA in-patients with VT in the setting of chronic ischemic heart disease is less well
defined. Ventricular tachycardia (VT) is a common complication of ischemic heart disease, with
significant associated morbidity and mortality.1,2 Traditionally, anti-arrhythmic medications have
formed the mainstay of treatment, despite the low efficacy, the risk of pro-arrhythmia and long
term adverse effects.3  Anti-arrhythmic surgery is successful in abolishing VT, however, the
operative mortality in most series was unacceptably high.4 Over the past 10 years, implantable
cardioverter defibrillators (ICDs) have become the treatment of choice for all but incessant VT.
This treatment is based on the evidence of a number of studies which have shown that ICDs
reduce overall mortality in certain subgroups of patients with ischemic heart disease with
documented VT5, 6, or even in the absence of previously documented VT7. 
            The development of anti-tachycardia pacing algorithms has significantly reduced the need
for cardioversion8 and resulted in much improved patient acceptance of such devices. Whilst
ICDs are associated with significant  mortality  benefits  in-patients  with  ischemic  heart
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disease and VT, they do not actually prevent the onset of arrhythmia and remain relatively
contraindicated in-patients with frequent arrhythmic episodes. In addition the implantation and
function of an ICD can contribute to pathological anxiety and depression in some patients.9
Furthermore, ICD therapy is relatively expensive, when considered over the expected lifetime of
particularly younger patients. In-patients with ischemic heart disease RFA has developed
predominantly an adjunctive role in patients with incessant or highly symptomatic, drug
refractory VT. 
Defining the Substrate for ventricular tachycardia in ischemic heart disease
            VT in the setting of ischemic heart disease is predominantly manifest as monomorphic
VT, caused by stable reentrant circuits.10,11 Whilst polymorphic VT and primary ventricular
fibrillation are seen in patients with ischemic heart disease these more often relate to acute
biochemical, ischemic or pharmacological insults; whilst ablation has been proposed for these
arrhythmias12, correction of the underlying abnormalities form the first line of treatment.
            In simple terms the mechanism of reentry in ischemic heart disease relates to zones of
heterogeneous conduction, typically at the edge of myocardial scars. Residual functioning
myocytes at the edge of, or interspersed within, myocardial fibrous scar create zones of slow
conduction   and   conduction   block.13  When   appropriately   located   and   with   appropriate
electrophysiological properties, these slow conduction zones can take the form of a discrete
electrical channel or isthmus critical to the initiation and continuation of VT. 
            The re-entrant VT circuit utilizes the slow conduction properties of the critical isthmus.
(Fig 1) The electrical activity propagates relatively slowly along the isthmus during diastole and
forms a silent zone on the surface ECG. When electrical activity reaches the exit zone it rapidly
propagates throughout the ventricular myocardium, giving rise to mechanical systole and the
QRS complex on the surface ECG. The electrical wavefront courses a loop through the
myocardium before returning to the entrance zone and repeating the isthmus passage. 14 The
diagrammatic representation of re-entry in Fig 1 is a simplistic description of a process, which
can  be  highly complex.   The  reentry  circuits   can  be  multiple   with shared  and separate
components; the circuits can be located in the endocardium, epicardium, transmuraly or
throughout   each   of   these   zones.   The   isthmuses   can   vary   significantly   in   length   and
electrophysiological properties. The regions of conduction block can be formed by scar tissue or
by anatomical boundaries (typically mitral annulus) and can manifest absolute conduction block
or functional conduction block developing only during VT. A comprehensive knowledge of the
anatomy and electrophysiology is fundamental to approaching ablation of VT in ischemic heart
disease.
 Mapping techniques
            
            Electrophysiological mapping techniques are primarily focused to identify appropriate
sites for ablation.  In the mapping of VT in the setting of ischemic heart disease, the fundamental
task is to identify and understand the critical VT isthmus. A number of different techniques have
been developed to guide mapping.
Mapping During VT
Early systolic Activity
            Traditional  mapping  approaches  during  VT  have  focused  on identification of earliest
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Figure   1:  Schematic   representation   of   the   re-entrant   circuit   of   ventricular
tachycardia. The circuit has a central critical isthmus located in a position
intimately related  to the scar border zone. The isthmus can be formed between the
scar zone and normal myocardium, within or between two scar zones or between
the scar zone and an anatomical boundary such as the mitral valve.
               The electrical activation travels slowly through the isthmus before
breaking out into normal myocardium at the exit zones. The circuit courses a
number of possible routes (outer loops, inner loops or both) before returning to the
critical isthmus at the entrance zone.
systolic activation. The principle is that the electrical activation that precedes the QRS complex
represents the breakout point of the VT into relatively normal myocardium. Fast moving discrete
activity preceding the surface QRS by at least 30 msec is regarded as early activation. As seen in
Figure 2, the activity preceding the surface ECG will be recorded at the exit zone. Whilst
identification of the exit zones is important, ablation here alone is rarely sufficient to eliminate
the re-entry circuit.
Diastolic potentials
            Slow moving activity during diastole can be identified in the critical isthmus during
VT.11,15 The timing of this activity will become progressively earlier as the mapping moves
from the exit to the entrance. Whilst this is often a useful finding, alone it is inconsistent; blind
loops and far field potentials can give rise to diastolic activity that is unrelated to the
criticalisthmus. The diastolic potentials which arise in the critical isthmus will remain associated
with VT during entrainment mapping (described below), whilst diastolic potentials arising from
bystander areas should be dissociated from the VT during entrainment.15 The morphology of the
diastolic activity has also been studied to predict the location of the critical isthmus but has
limited additional value.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 4(2): 63-72 (2004)David O’Donnell, Voltaire Nadurata, “Radiofrequency Ablation for Post Infarction     66
Ventricular Tachycardia”
Figure 2:  Intra-cardiac electrogram recordings from a single patient with typical re-entrant
ventricular tachycardia related to a previous inferior infarction. The recordings were obtained
sequentially and superimposed. 
            The exit zone is identified by a discrete electrogram, which occurred 33 msec before the
onset of the surface QRS. Pacing at this site in sinus rhythm produced a QRS complex, which
closely resembled that of the studied VT.
            The common isthmus is identified by a slow moving, complex, fractionated signal in late
diastole. This position was less than 1 cm from the exit site. Pacing at this site during VT (with
high local capture threshold) resulted in concealed entrainment, with a post pacing interval of
less than 20 msec different from the VT cycle length. Pacing in sinus rhythm produced a
complex similar to the VT being studied and a long stimulus to QRS onset. A complex late
potential was seen at this site in sinus rhythm. 
            The entrance zone and outer loop contained discrete local potentials, which were seen
early in diastole and mid QRS respectively.
            Radiofrequency ablation using an irrigated tip catheter applied at the site of the isthmus
recording terminated VT. The local lesion was consolidated with a linear ablation encompassing
the exit zone and extending to the mitral annulus. Following this lesion this VT morphology was
no longer inducible. 
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Entrainment Mapping
            Entrainment refers to a specific response of an arrhythmia to a pacing stimulus at rates
greater than the tachycardia cycle length.16 Whilst no one technique alone can fully identify the
re-entrant circuit in is entirety, entrainment mapping is perhaps of most use in localizing the
critical VT isthmus.11,17 The principles of entrainment utilize the unique electrophysiological
properties, which lead to the establishment of a reentrant arrhythmia with an excitable gap.
Whilst a complete discussion of entrainment is beyond the scope of this paper, the principles
warrant discussion. 
            Pacing that leads to classical entrainment will result in temporary QRS fusion. If pacing
is conducted from within the critical isthmus of the arrhythmia, the resultant QRS morphology
should match that of the VT being studied; this is known as entrainment with concealed fusion
or concealed entrainment. During concealed entrainment, the duration from the pacing stimulus
to the surface QRS onset can localize the pacing site within the isthmus. The shortest S-QRS will
be recorded at the exit zone and this will progressively lengthen as the site of pacing moves
along the isthmus towards the entrance zone. 
            When pacing at a site within the re-entry circuit, the post pacing interval, from the last
pacing stimuli to the return electrogram seen at the pacing site should be similar to the cycle
length of the VT. (Post pacing interval – VT cycle length less than 30 msec.) With the
complexity of the reentry circuits, neither concealed entrainment nor the post-pacing interval are
completely accurate in identifying the isthmus zone.18 The utilization of entrainment mapping is
further limited by a number of factors including: the dependence upon haemodynamically
tolerated rhythms to enable mapping, the ability to capture the local myocardium, which can be
difficult in zones of scar with high capture threshold and the often complex and fractionated
signals within the scar border zone which complicate interpretation. 
Mapping During Sinus Rhythm
            Mapping during VT can be limited by haemodynamic instability, difficulties in inducing
VT and uncertainties regarding the clinical significance of induced VTs. Mapping during sinus
rhythm is designed to delineate the anatomical and electrophysiological substrate, which
predispose to reentry and VT. Mapping in the area of previous infarction can identify these
potential areas of abnormal conduction.  
            Different groups perform substrate mapping using a combination of different techniques.
Analysis of electrograms during sinus rhythm can identify regions of fractionated electrograms
and late potentials, which are markers of abnormal, slowed conduction. Voltage mapping
identifies scar zones and the scar border zones in which most isthmuses are located. Pacing
threshold   maps   add   additional   information   to   the   voltage   map   to   identify   electrically
heterogeneous areas. Pacemapping to produce a QRS morphology that is similar to that during
VT can roughly localize the site of the reentry circuit exit. The duration from the pacing stimulus
to the onset of QRS (S-QRS duration) can further identify abnormal substrate that predisposes to
reentry. 
               None of these above techniques have adequate specificity to be used alone, but in
combination can successfully identify regions of abnormal conduction. Substrate mapping does
not identify a discrete point for ablation, but rather a zone or region of abnormal myocardium
with the potential to facilitate reentry. 
Newer Mapping Tools
            The newer mapping tools utilized in electrophysiology all have the potential to facilitate
the mapping and ablation of VT. By providing reproducible anatomical information the mapping
tools each have the ability to simplify mapping approaches and to guide the delivery of optimal
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radiofrequency ablation lesions. 
            CARTO (Biosense-Webster, Diamond Bar, USA) is the most studied mapping tool to aid
ablation of ventricular tachycardia. CARTO is most useful in providing accurate substrate maps.
The EnSite 3000 multielectrode array (Endocardial Solutions, St Pauls, USA) uses non-contact
virtual electrograms which can not only provide myocardial substrate information, but can map
ventricular activation with a little as one recorded cardiac cycle. 
            As technology improves, the mapping systems will become an integral part of the study
of ventricular tachycardia. In the foreseeable future, however, the mapping tools will provide
guidance and accuracy, but will not replace the need for an operator with a full grasp of
electrophysiology and anatomy.
 Ablation Techniques 
        The ablation of VT in the setting of ischemic heart disease has been performed according to
two basic strategies. The first strategy involves induction of ventricular tachycardia, mapping
and targeted ablation.19,20,21,22,23,24,25,26,27 The second strategy involves substrate mapping in
sinus rhythm and linear ablation to eradicate regions of abnormal myocardium with the potential
to facilitate reentry.28 It is difficult to comment on the relative success of the different
approaches as most centers now use a combination of these two approaches. 
               Targeted ablation of a single morphology of haemodynamically stable VT can be
successful in over 80% of cases.19,20,21,22,23,24,25,26,27 Unfortunately, acute procedural success
does not always predict long term recurrence of VT. Some studies have reported a recurrence of
VT of close to 50% if a single dominant morphology is successfully ablated.25As such the trend
in ablation of VT has been to target all inducible morphologies of monomorphic sustained VT.
When multiple morphologies of VT are targeted the acute success rate diminishes proportional
to   the   number   of   different   morphologies   and   diminishes   further   when   the   VT   is
hemodynamically   unstable.26,29   However,   even   in-patients   with   more   than   3   inducible
morphologies of VT or with hemodynamically unstable VT procedural success rates are
approach 60%.26
        The linear approach pioneered by Marchlinski28 was acutely successful in eradicating or
modifying VT in 7 of 9 patients with a recurrence in less than 20%. Using a combination
approach large series report an acute success rate of 60-80%, with a longer-term freedom from
VT of 75-95% in those successfully ablated. Recent developments in catheter technology have
led to the use of irrigated tip catheters, which enable deeper lesions to be formed. These catheters
have been shown to be more successful in the acute termination of VT30, long term data is not
yet available. Alternative approaches via the epicardium31 and via the coronary arteries32 have
also been used but as yet are not applicable beyond a few expert centers.
Complications
            In the larger reported series, significant complications (cardiac tamponade, TIA, complete
heart block) occurred in 5 – 10% of patients and minor complications (access site hematoma,
nausea etc) in a further 5 – 10% of patients.19,20,21,22,23,24,25,26,27,28,29
Defining success
            Previous series have reported the recurrence of VT following a successful procedure to
vary from15 - 40%19,20,21,22,23,24,25, depending upon the specific definitions used. The non-
inducibility of clinical VT is often regarded as a marker of success following RFA. However, it
has been shown that even following successful ablation of all clinical VTs, the presence of
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inducible non-clinical VT is associated with an increased incidence of recurrent VT21. Indeed,
following ablation of all morphologies of clinical VT in one series, further morphologies, which
had not been documented clinically, were inducible in 83% of patients26.
            Because of the difficulties with recognizing and defining clinical VT, we prefer to define
success based on the level of stimulation required to induce VT rather than the particular
morphology of VT induced.33 Prior to ablation, we conduct a stimulation protocol from the right
ventricular apex comprising an 8 beat drive followed by up to 5 extrastimuli introduced at
decreasing cycle lengths until refractoriness was reached. At the end of the ablation procedure
we repeat the stimulation protocol. Procedural success was defined by comparing the results of
the two stimulation protocols. 
Acute success – No monomorphic VT induced at refractoriness of 5 extra stimuli. 
Modified Result –Monomorphic VT only inducible by 2 extra stimuli more aggressive than at
baseline.
Failed Procedure - Monomorphic VT inducible at similar levels to baseline.
            Using this protocol we were able to accurately predict the patients who will remain free
of further VT following radiofrequency ablation. In patients with a minimum follow up of 12
months the rate of recurrent VT with either a complete success or a modified result was 4%,
compared with 66% amongst patients with a failed procedure33. 
 Patient selection
            
               At one end of the spectrum, the patient with incessant or intractable ventricular
tachycardia,   resistant   to   pharmacotherapy   and   overdrive   pacing   and   requiring   frequent
cardioversion is an obvious candidate for ablation of ventricular tachycardia. At the other end of
the spectrum there is presently no role for ablation in the sense of primary prevention. 
            Patients with frequent episodes of VT should be considered for ablation. The threshold
for deciding to undergo ablation should consider the local expertise, the frequency of episodes,
patient and economic factors. Comprehensive data has shown a substantial mortality benefit
supporting the use of ICDs in-patients with post infarction VT. At present ablation should ideally
be considered to have a role as an adjunct to an ICD in-patients with highly symptomatic VT.
            As mapping and ablation techniques develop and the accuracy of predicting the long-term
outcome improves, the role of RFA may expand, making it the therapy of first choice in a
growing proportion of patients. Perhaps with time ICDs may be reserved as the treatment for
failed ablation procedures or for prophylactic indications, particularly in parts of the world where
widespread implantation of ICDs is financially impractical. Even if ICDs remain justified on the
basis of residual uncertainty, the quality of life is likely to be improved by the reduction in
discharges resulting from catheter ablation. 
 Conclusions
               Radiofrequency catheter ablation of patients with highly symptomatic, sustained,
monomorphic post infarction VT can be performed with high success rate and acceptable
procedural complication rate. The procedure can be successfully applied to a wide spectrum of
patients including those with multiple morphologies of VT and hemodynamically unstable VT.
The   procedure   at   present   requires   extensive   understanding   of   anatomical   and
electrophysiological principles and is prolonged and technically demanding. Its application
beyond a few expert centers is dependent upon electrophysiological and technological advances. 
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